Dr. Sulaiman Al Habib Medical Services Group Company
Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
4013.sr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) measures how much investors pay for each dollar of the company's trailing earnings. 4013.SR's current PE ratio of 32.60x is calculated by dividing its stock price of $218.70 by its TTM earnings per share of $6.71. −24.8% discount vs 5Y avg 43.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2015 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 11 fiscal years · Front-end computedMinQ1 · 25%36.1x
MedianQ3 · 75%48.6x
Max
At 32.60x, 4013.SR's current P/E is within its average historical range over the past 11 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Dr. Sulaiman Al Habib Medical Services Group CompanyYou 4013.SR | $76.5B | 32.60x | +23.6% | $6.71 |
 Mouwasat Medical Services Company 4002.SR | $13.3B | 16.22x | -38.5% | $4.11 |
 Dallah Healthcare Company 4004.SR | $11.6B | 23.59x | -10.6% | $5.32 |
 National Medical Care Company 4005.SR | $4.8B | 20.01x | -24.1% | $7.13 |
 Al Hammadi Holding Company 4007.SR | $4.5B | 18.53x | -29.7% | $1.51 |
 Dr. Soliman Abdel Kader Fakeeh Hospital Company 4017.SR | $8.9B | 27.03x | +2.5% | $1.26 |
 Canadian General Medical Center Complex Company 9518.SR | $697M | 52.86x | +100.4% | $0.13 |
Industry Average 6 peers with valid PE | — | 26.37x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 37.46x | $6.86 | -11.6% | |
2024-12-31 FY2024 | 42.39x | $6.62 | -12.8% | |
2023-12-31 FY2023 | 48.58x | $5.85 | +2.8% | |
2022-12-31 FY2022 | 47.24x | $4.72 | +15.1% | |
2021-12-31 FY2021 | 41.04x | $3.93 | +13.5% | |
2020-12-31 FY2020 | 36.14x | $3.02 | +63.4% | |
2019-12-31 FY2019 | 22.12x | $2.49 | -7.9% | |
2018-12-31 FY2018 | 24.02x | $2.29 | -18.1% | |
2017-12-31 FY2017 | 29.34x | $1.87 | +53.9% | |
2016-12-31 FY2016 | 19.06x | $2.89 | +31.6% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) measures how much investors pay for each dollar of the company's trailing earnings. 4013.SR's current PE ratio of 32.60x is calculated by dividing its stock price of $218.70 by its TTM earnings per share of $6.71.
Frequently asked questions
4013.SR pe ratio · 6 questions4013.SR's current PE ratio is 32.60x as of 2026-06-15, based on a stock price of $218.70 and TTM EPS of $6.71. Data sourced from Financial Modeling Prep via 4013.SR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Dr. Sulaiman Al Habib Medical Services Group Company SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15